<DOC>
	<DOCNO>NCT01884701</DOCNO>
	<brief_summary>The current study prospective , single-arm , non-randomized , multi-center study evaluate outcome ENABLER-P Catheter System cross chronic total occlusion endovascular intervention femoral-popliteal occlusive disease .</brief_summary>
	<brief_title>Accessing Peripheral Occluded LesiOns II ( APOLO-II )</brief_title>
	<detailed_description />
	<criteria>Documentation previous attempt OR concurrent reasonable attempt ( least 5 minute ) procedure , demonstrate resistance conventional guidewire crossing ; Patient must objective evidence low extremity ischemia ; Totally occlusive lesion native femoropopliteal artery classify angiographically absolute ( 100 % occlusion flow ) , antegrade fill beyond occlusion visible ; Target occlusion length &gt; 1cm ≤ 30 cm ; Patient 's reference vessel diameter ≥ 4.0 mm ≤6.0 mm ( visual angiographic estimation ) Patient must acceptable candidate PTA , peripheral artery bypass surgery peripheral artery stent implantation ; Female patient child bear potential must negative pregnancy test within 48 hour prior study procedure ; Patient must inform nature study , agree provision , provide write informed consent ; Patient ≥ 21 year age . Patient hypersensitivity contraindication aspirin , heparin , Plavix radiographic contrast agent adequately premedicated ; The patient require immediate treatment one occlude vessel , combination graft native vessel ; Patient plan femoropopliteal intervention schedule within 30 day index procedure ; The patient currently participate another investigational drug device trial may conflict study data collection complete entire followup period ; Patient collateral flow distal occlusion ; Patient 's target occlusion dissection occur within past 30 day cause guidewire attempt ; Patient history bleeding diatheses , coagulopathy refuse blood transfusion case emergency ; Patient suffer recent ( within past 6 month ) significant gastrointestinal ( GI ) bleeding ; Patient 's target lesion vessel proximal target lesion reveals significant ectasia , dissection , aneurysm thrombus ; Patient medical illness ( i.e. , cancer congestive heart failure ) may cause patient noncompliant protocol , confound data interpretation associate lifeexpectancy less 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Chronic Total Occlusion CTO</keyword>
</DOC>